Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BranchOut Food Inc. Announces First Quarter 2026 Earnings Call and Shareholder Update
-
Lifecore Biomedical to Participate at CDMO Live Europe
-
Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
-
Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress
-
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
-
Espey Mfg. & Electronics Corp. reports third quarter results
-
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
-
Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference
-
Red Cat Announces Proposed Public Offering of Common Stock
-
Biomea Fusion to Participate at Upcoming Investor Conferences
-
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
-
PEDEVCO to Participate in the LD Micro Invitational XVI Conference
-
XBP Global Schedules Conference Call for First Quarter 2026 Financial Results
-
Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers
-
GrowGeneration Reports First Quarter 2026 Financial Results
-
High Roller Technologies Provides Business Update for Prediction Markets Launch; Reports First Quarter 2026 Results
-
Mobile Infrastructure Reports First Quarter 2026 Financial Results
-
Phillips Edison & Company Declares Monthly Dividend Distributions; Announces Results of Annual Meeting of Stockholders
-
MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance
-
TELA Bio Reports First Quarter 2026 Financial Results
-
Astera Labs Announces Second Quarter 2026 Financial Conference Participation
-
Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment
-
Black Rock Coffee Bar Announces Jon Vingo as Chief Development Officer
-
Jushi Holdings Inc. Reports First Quarter 2026 Financial Results
-
Arteris Announces Financial Results for the First Quarter and Estimated Second Quarter and Updated Full Year 2026 Guidance
-
iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
-
Varonis to Present at Upcoming Investor Conferences
-
Elevra Lithium Announces Purchase of Moblan Offtake Rights
-
Robinhood Markets, Inc. to Present at the J.P. Morgan Global Technology, Media and Communications Conference on May 19, 2026
-
Digital Realty Declares Quarterly Cash Dividends for Common and Preferred Stock
-
Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
-
Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update
-
Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates
-
Hour Loop Reports First Quarter of 2026 Results
-
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Datadog to Present at Upcoming Investor Conference
-
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
-
Nyxoah Reports First Quarter 2026 Financial and Operating Results
-
Surrozen to Present at Upcoming Healthcare Investor Conference
-
Saucony® Appoints Wendy Kula as Chief Marketing Officer
-
CSX Corporation Declares Quarterly Dividend
-
Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results
-
Kura Oncology Reports First Quarter 2026 Financial Results
-
Aura Biosciences to Participate in Upcoming Investor Conferences
-
IZEA Reports Q1 2026 Revenue of $6.6 Million, Strengthens Enterprise Client Base, Launches AI-Powered ZED Platform
-
BIO-key Shares Expected to Temporarily Move to OTC™ Markets Tomorrow, Wednesday May 13th Following Nasdaq Suspension After Today’s Market Close; BIO-key is Seeking to Restore Nasdaq Listing Expedi
-
Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
-
Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
-
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees

